Major drugmakers are reportedly looking to maintain profits amid an initiative to charge Americans less
US pharmaceutical giants are seeking to circumvent US President Donald Trump’s campaign to lower drug costs for Americans, which may cost Europeans access to medicine, the Financial Times reported on Sunday.
Since last year, Trump has pressured big pharma to benchmark key medicines sold in the US to prices in other countries, citing unfair pricing differences. As of January, 16 major global drug companies have agreed to cut prices in exchange for three years of tariff relief.
However, Pfizer CEO Albert Bourla has said that the pharma giant is…
Read the full article at RT.COM
